Baxter International Inc. (NYSE:BAX) Plans Quarterly Dividend of $0.01

Baxter International Inc. (NYSE:BAX) declared a quarterly dividend on Wednesday, April 29th. Stockholders of record on Friday, May 29th will be paid a dividend of 0.01 per share by the medical instruments supplier on Wednesday, July 1st. This represents a c) dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, May 29th.

Baxter International has decreased its dividend payment by an average of 0.1%per year over the last three years. Baxter International has a payout ratio of 1.5% meaning its dividend is sufficiently covered by earnings. Analysts expect Baxter International to earn $2.03 per share next year, which means the company should continue to be able to cover its $0.04 annual dividend with an expected future payout ratio of 2.0%.

Baxter International Trading Down 1.6%

Shares of NYSE:BAX traded down $0.28 during trading on Friday, reaching $17.30. 5,812,539 shares of the company were exchanged, compared to its average volume of 9,483,563. The firm has a market capitalization of $8.93 billion, a PE ratio of -9.34, a P/E/G ratio of 1.20 and a beta of 0.62. The business’s fifty day simple moving average is $17.92 and its 200-day simple moving average is $19.18. Baxter International has a 12-month low of $15.73 and a 12-month high of $32.68. The company has a debt-to-equity ratio of 1.55, a current ratio of 2.31 and a quick ratio of 1.56.

Baxter International (NYSE:BAX) last issued its earnings results on Thursday, April 30th. The medical instruments supplier reported $0.36 EPS for the quarter, topping analysts’ consensus estimates of $0.31 by $0.05. The business had revenue of $2.70 billion for the quarter, compared to analyst estimates of $2.62 billion. Baxter International had a negative net margin of 8.51% and a positive return on equity of 16.95%. The company’s quarterly revenue was up 2.9% compared to the same quarter last year. During the same period last year, the company posted $0.62 earnings per share. On average, research analysts anticipate that Baxter International will post 1.91 EPS for the current year.

Institutional Investors Weigh In On Baxter International

Several institutional investors have recently bought and sold shares of BAX. Basepoint Wealth LLC acquired a new stake in Baxter International in the fourth quarter valued at approximately $26,000. Imprint Wealth LLC acquired a new stake in Baxter International in the third quarter valued at approximately $27,000. MUFG Securities EMEA plc acquired a new stake in Baxter International in the second quarter valued at approximately $46,000. Los Angeles Capital Management LLC acquired a new stake in Baxter International in the fourth quarter valued at approximately $46,000. Finally, McMillan Office Inc. acquired a new stake in Baxter International in the fourth quarter valued at approximately $54,000. 90.19% of the stock is currently owned by institutional investors and hedge funds.

About Baxter International

Baxter International Inc is a global healthcare company that develops, manufactures and markets a broad portfolio of medical products, pharmaceutical therapies and biotechnology-based solutions. The company’s primary business activities are organized around renal care, medication delivery, acute therapies, pharmacy automation, surgical care and biotechnology. Baxter’s offerings are designed to support patient care in hospitals, dialysis centers, nursing homes and other healthcare facilities worldwide.

In the renal care segment, Baxter provides hemodialysis and peritoneal dialysis systems, water treatment equipment and related disposables, including dialyzers, bloodlines and catheters.